Skip to main content
. Author manuscript; available in PMC: 2016 Oct 12.
Published in final edited form as: Transfusion. 2013 Apr 29;53(10 Pt 2):2459–2466. doi: 10.1111/trf.12218

TABLE 1.

Comparison of percentage positive results in replicate tests (n = 6 per sample) of different categories of HBV NAT–yield samples in different ID- and MP-NAT options

Clinical status Donations Number of tests Ultrio
Ultrio plus
TaqScreen
ID-NAT
MP4
MP8
ID-NAT
MP4
MP8
MP6
Positive % Positive % Positive % Positive % Positive % Positive % Positive %
First WP 22 132 110 83 78 59 75 57 123 93 105 80 93 70 111 84
Vaccine breakthrough* 10 60 44 73 30 50 27 45 51 85 40 67 35 58 38 63
Second WP 15 90 55 61 27 30 20 22 57 63 32 36 22 24 13 14
OBI 29 174 87 50 51 29 30 17 129 74 78 45 48 28 68 39
OBI a-HBs 28 168 91 54 58 35 40 24 120 71 78 46 56 33 66 39
Unknown 3 18 8 44 5 28 4 22 12 67 6 33 7 39 4 22
All 107 642 395 62 249 39 196 31 492 77 339 53 261 41 300 47
*

Probable vaccine breakthrough infections.

Anti-HBs–negative OBI.

Anti-HBs–positive OBI.